Dan Dufner is a partner in the Mergers & Acquisitions Group at White & Case, based in the New York office.
His practice focuses on representing US public companies and includes US domestic transactions, as well as cross-border transactions throughout Europe, Asia and Australia.
Dan has worked extensively for longstanding clients Anthem (formerly WellPoint), DISH Network and EchoStar, and he is valued by his clients for his ability to handle complex cases involving different parties with competing interests.
Dan received Lexology's 2018 Client Choice Award for New York M&A. He is also ranked as a "Leading Individual" for M&A in Chambers USA and has been recognized by The American Lawyer as "Dealmaker of the Week" and "Dealmaker in the Spotlight."
Dan received his BA from University of Pennsylvania in 1992 and his JD from American University, Washington College of Law, summa cum laude, in 1995.
Dan began advising longtime client Anthem in early 2015 in connection with its proposed pursuit and recently terminated US$54.2 billion agreement to acquire Cigna Corporation. This transaction, which garnered front-page coverage for over two years, marks the largest transaction ever proposed in managed care and the first merger agreement in the industry that resulted from a public "bear hug" approach.
Other recent matters include the representation of:
- Anthem, Inc. its acquisition of Aspire Health, Inc., the nation's largest non-hospice, community-based palliative care provider.
- Anthem, Inc. in its acquisition of America's 1st Choice, a privately-held for-profit Medicare Advantage organization that offers HMO products in Florida and South Carolina.
- Anthem, Inc. in its acquisition of HealthSun, one of the fastest-growing integrated Medicare Advantage health plans and healthcare delivery networks in Florida, from Summit Partners.
- EchoStar Corporation in its agreement to enter into a joint venture with Yahsat, a leading global satellite operator based in the United Arab Emirates and wholly owned by Mubadala Investment Company, to provide commercial Ka-band satellite broadband services across Africa, the Middle East and southwest Asia.
- EchoStar Corporation in its proposed acquisition of LSE-listed Inmarsat plc.
- EchoStar Corporation in a strategic transaction with DISH Network Corporation involving the transfer of EchoStar's technologies business to DISH in exchange for the redemption of EchoStar preferred tracking stock issued in a prior transaction.
- Vertex Pharmaceuticals, Inc. in its acquisition of cystic fibrosis drug, CTP-656, from Concert Pharmaceuticals, Inc.